CYTOPOINT™ is a safe choice for virtually every dog with atopic dermatitis
No known drug interactions—safe in combination with commonly used medications, including1:
APOQUEL® (oclacitinib tablet), corticosteroids, cyclosporine and antihistamines
Treatments such as parasiticides, antibiotics, antifungals, vaccines, NSAIDs and allergen-specific immunotherapy
Targeted mechanism of action may help minimize side effects and avoid unwanted effects on immune function1,2
Does not burden the liver or kidneys
CYTOPOINT functions like naturally occurring antibodies and is eliminated via normal protein degradation pathways in the same way, which does not involve the liver or kidneys
Safe to use in dogs of any age1,2
Can be used in dogs with concomitant diseases
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
References: 1. Data on file, Study Report No. C961R-US-13-051, Zoetis LLC. 2. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j. 1365-3164.2012.01098.x.3. Data on file, Study Report No. C362N-US-13-042, Zoetis LLC.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
Zoetis Services LLC. All rights reserved. CYT-00090